Posted by Michael Wonder on 30 May 2017
National MP urges PHARMAC to consider 'gold standard' neuroendocrine cancer treatment
30 May 2017 - A National MP and chair of Parliament's health committee says it's important PHARMAC consider funding a "gold standard" cancer treatment.
Almost 50 New Zealanders with neuroendocrine cancer are currently raising tens of thousands of dollars to pay for treatment in Australia because the life-prolonging treatment isn't available here.
Tamaki MP and chair of Parliament's health committee Simon O'Connor met two patients today, Chris Holmes and Siobhan Conroy, posing with them and a petition that will go to the drug-buying agency PHARMAC.
